JP2014502848A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014502848A5 JP2014502848A5 JP2013547936A JP2013547936A JP2014502848A5 JP 2014502848 A5 JP2014502848 A5 JP 2014502848A5 JP 2013547936 A JP2013547936 A JP 2013547936A JP 2013547936 A JP2013547936 A JP 2013547936A JP 2014502848 A5 JP2014502848 A5 JP 2014502848A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- lcmv
- heavy chain
- chain variable
- variable region
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161430822P | 2011-01-07 | 2011-01-07 | |
| US61/430,822 | 2011-01-07 | ||
| PCT/IB2012/000293 WO2012093340A2 (en) | 2011-01-07 | 2012-01-06 | Viral diagnostics |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014502848A JP2014502848A (ja) | 2014-02-06 |
| JP2014502848A5 true JP2014502848A5 (https=) | 2015-02-26 |
Family
ID=45878971
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013547936A Pending JP2014502848A (ja) | 2011-01-07 | 2012-01-06 | ウイルス診断 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US8883429B2 (https=) |
| EP (2) | EP2664680A1 (https=) |
| JP (1) | JP2014502848A (https=) |
| CN (1) | CN103597098A (https=) |
| AU (1) | AU2012204757A1 (https=) |
| CA (1) | CA2823876A1 (https=) |
| WO (1) | WO2012093340A2 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2604695B1 (en) | 2007-12-27 | 2022-11-16 | Universität Zürich | Replication-defective arenavirus vectors |
| US9849192B2 (en) | 2009-11-18 | 2017-12-26 | Rutgers, The State University Of New Jersey | Targeting tumor cells with chemotherapeutic agents conjugated to matriptase antibodies |
| CA2818237C (en) | 2009-11-18 | 2021-05-18 | University Of Medicine And Dentistry Of New Jersey | Targeting tumor cells with chemotherapeutic agents conjugated to matriptase antibodies |
| CA2887037A1 (en) * | 2012-10-02 | 2014-04-10 | Rutgers, The State University Of New Jersey | Specific delivery of toxins conjugated with antibodies to activated matriptase |
| EP2968506B1 (en) | 2013-03-15 | 2019-07-31 | Université de Genève | Anti-mycobacterial vaccines |
| CN115058452A (zh) | 2013-12-03 | 2022-09-16 | 霍欧奇帕生物科技有限公司 | Cmv疫苗 |
| US10342861B2 (en) * | 2014-05-27 | 2019-07-09 | University Of Rochester | Arenavirus vaccine |
| JP7145374B2 (ja) | 2016-03-18 | 2022-10-03 | ラトガース ザ ステイト ユニバーシティー オブ ニュージャージー | インビボでの切断可能連結部分によって抗マトリプターゼ抗体にコンジュゲートされた化学療法剤を用いる腫瘍細胞の標的化 |
| DE102018215551A1 (de) * | 2018-09-12 | 2020-03-12 | Virolutions Biotech Gmbh | Verfahren zur Herstellung eines antitumoralen Arenavirus sowie Arenavirusmutanten |
| KR102446014B1 (ko) * | 2022-04-19 | 2022-09-23 | 주식회사 웰에이블 | 저시력자용 진단키트 전용 커버 |
| CN119080935B (zh) * | 2024-10-11 | 2026-04-14 | 上海市同仁医院 | 一种抗人SMIM45-107aa单克隆抗体及其用途 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
-
2012
- 2012-01-06 CN CN201280012143.3A patent/CN103597098A/zh active Pending
- 2012-01-06 CA CA 2823876 patent/CA2823876A1/en not_active Abandoned
- 2012-01-06 EP EP20130179952 patent/EP2664680A1/en not_active Ceased
- 2012-01-06 WO PCT/IB2012/000293 patent/WO2012093340A2/en not_active Ceased
- 2012-01-06 AU AU2012204757A patent/AU2012204757A1/en not_active Abandoned
- 2012-01-06 EP EP12710536.9A patent/EP2661509A2/en not_active Withdrawn
- 2012-01-06 JP JP2013547936A patent/JP2014502848A/ja active Pending
- 2012-01-06 US US13/345,334 patent/US8883429B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014502848A5 (https=) | ||
| Pas et al. | Hepatitis E virus infection among solid organ transplant recipients, the Netherlands | |
| Flyak et al. | Cross-reactive and potent neutralizing antibody responses in human survivors of natural ebolavirus infection | |
| Zou et al. | Haemorrhagic fever with renal syndrome: literature review and distribution analysis in China | |
| Tran et al. | Molecular epidemiology and disease severity of human respiratory syncytial virus in Vietnam | |
| JP2016136963A5 (https=) | ||
| JP2013500941A5 (https=) | ||
| Byrne et al. | Structural basis for antibody recognition of vulnerable epitopes on Nipah virus F protein | |
| JP2016516400A5 (https=) | ||
| RU2018108048A (ru) | Новые анти-pd-1 антитела | |
| JP2014511179A5 (https=) | ||
| JP2014512809A5 (https=) | ||
| JP2013539454A5 (https=) | ||
| JP2013531655A5 (https=) | ||
| Goeijenbier et al. | The hanta hunting study: underdiagnosis of Puumala hantavirus infections in symptomatic non-travelling leptospirosis-suspected patients in the Netherlands, in 2010 and April to November 2011 | |
| JP2010527939A5 (https=) | ||
| JP2016530223A5 (https=) | ||
| JP2014500960A5 (https=) | ||
| JP2018507254A5 (https=) | ||
| JP2014509860A5 (https=) | ||
| McCall et al. | Targeted metagenomic sequencing for detection of vertebrate viruses in wastewater for public health surveillance | |
| JP2016534022A5 (https=) | ||
| Huang et al. | Impact of genetic heterogeneity in polymerase of hepatitis B virus on dynamics of viral load and hepatitis B progression | |
| Parray et al. | A broadly neutralizing monoclonal antibody overcomes the mutational landscape of emerging SARS-CoV-2 variants of concern | |
| Verma et al. | Influence of Th1 versus Th2 immune bias on viral, pathological, and immunological dynamics in SARS-CoV-2 variant-infected human ACE2 knock-in mice |